IBR Connecting the Dots – Navigating Cannabis and Psychedelics


Welcome to our latest video series – Connecting the Dots.

The IBR team brings you a weekly digest of the latest happenings in the markets, global events and political situations.

Amongst the thousands of stocks to choose, there are plenty to be bullish about, but many that are just plain old BS. We cover both.


In this Episode: The Cannabis Industry

  • Industry consolidation and write-offs.
  • Not the right time to invest – YET.
  • How are consumers accepting Cannabis products?
  • M2Bio (OTC: $WUHN) Cannabis Acquisition in Lesotho.
  • Interesting opportunities in Cannabis-industry related companies.


In this Episode: The Psychedelics Industry

  • What is up and down in the Psychedelics Industry?
  • Are the cannabis cowboys resaddling into the psychedelic space?
  • Psychedelics lifecycle stage and investing checklist.
  • Watchlist: MindMed (NEO: $MMED), M2Bio (OTC: $WUHN), Compass Pathways (NASDAQ: $CMPS).
  • The difference between Psychedelics and Cannabis Industries.


As always, hit us up on Twitter at @IBullReport and let us know what do you think.

Curious for more? Subscribe here to receive our weekly stories.

Luka Marjanovic


Luka holds a Bachelor’s in International Business and a Master’s in International Management. During his undergraduate studies he worked as a research assistant in the field of Big Data; founded his own consulting firm providing services to local SME's in various sectors and invested in the capital markets; as well as working pro-bono providing education and career counselling. Prior to his business education, he studied Biology-and-Biotechnology, and served in the Danish Royal Army as Second Sergeant, leading and managing a group under extreme conditions and pressure. Luka has spent significant time abroad, living and working in seven different countries. When he's not in the office, he's chasing the next gusts windsurfing, carving the mountain snowboarding or out in the forest for a jog.